loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Aurobindo Pharma has completed the acquisition of Lannett Company

ICICIdirect Research 01 Jul 2026 DISCLAIMER

News: Aurobindo Pharma has completed the acquisition of Lannett Company LLC following receipt of US Federal Trade Commission approval on June 18, 2026. Effective June 29, 2026, Lannett has become a wholly owned subsidiary of APUSA and will continue operating as Lannett Company LLC. The integration process has commenced immediately, with Aurobindo also onboarding over 400 Lannett employees, strengthening its manufacturing, operational capabilities and US generics platform.

View: The acquisition will significantly expand Aurobindo USA’s product offering (differentiated pipeline of complex generics and controlled substances) in this segment while adding a US based manufacturing facility with capacity to scale production to ~ 4 billion doses annually to its network. Besides this, the acquisition is anticipated to generate meaningful cost efficiencies, SG&A synergies, and operational integration advantages

Impact: Positive

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere